Permeability of three-dimensional fibrin constructs corresponds to fibrinogen and thrombin concentrations

BioResearch Open Access

Volumn 1, Issue 1, 2012, Pages 34-40

  Chiu, Cecilia L ^a   Hecht, Vivian ^a   Duong, Haison ^a   Wu, Benjamin ^a   Tawil, Bill ^a  

^a Engineering IV   (United States)

Author keywords

Diffusivity; Fibrin; Fibrinogen; Permeability; Pore size

Indexed keywords

DEXTRAN; FIBRIN; FIBRINOGEN; FLUORESCEIN; THROMBIN;

ARTICLE; BIOCHEMICAL COMPOSITION; CELL GROWTH; CELL MEMBRANE PERMEABILITY; CELL SIZE; FLOW MEASUREMENT; IN VITRO STUDY; MACROMOLECULE; MEMBRANE MICROPARTICLE; PRIORITY JOURNAL; PROTEIN TRANSPORT;

EID: 84872595548     PISSN: None     EISSN: 21647860     Source Type: Journal    
DOI: 10.1089/biores.2012.0211     Document Type: Article

References (25)

1. Sierra D. Fibrin sealant adhesive systems: a review of their chemistry, material properties, and clinical applications. J Biomater Appl. 1993;7:309-352.
2. Albes JM, Klenzner T, Kotzerke J, et al. Improvement of tracheal autograft revascularization by means of fibroblast growth factor. Ann Thorac Surg. 1994;57:444-449.
3. Amrani D. Wound healing: role of commercial fibrin sealants. Ann NY Acad Sci. 2001;936:566-579.
4. Tawil B. Fibrin and Its Applications. Review Article. In: An Introduction to Biomaterials. Guelcher SA, Hollinger JO (eds.). Boca Raton, FL: CRC Taylor & Francis; Chapter 7, pp. 105-120; 2005.
5. Duong H, Wu B, Tawil B. Fibrin matrices in tissue engineering. In: Natural Based Polymers for Biomedical Applications. Reis RL, Neves NM, Mano JF, et al. (eds.). Cambridge, United Kingdom: Woodhead Publishing Ltd.; 2008.
6. Duong H, Wu B, Tawil B. Modulation of 3-dimensional fibrin matrix stiffness by intrinsic fibrinogen-thrombin compositions and by extrinsic cellular activity. Tissue Eng. 2009;15: 1865-1876.
7. Budzynski AZ, Olexa SA. Localization of a fibrin polymerization site. J Biol Chem. 1981;256:3544-3549.
8. Horowitz BH, Varadi A, Scheraga HA. Localization of a fibrin #-chain polymerization site within segment thr-374 to glu-396 of human fibrinogen. Proc Natl Acad Sci USA. 1984; 81:5980-5984.
9. Khare A, Woo L, Mclean A, et al. Mechanical characterization of fibrin gels. Blood Coag Fibrinolysis. 1998;9:105.
10. DeMaat MPM, Laurens N, Koolwijk P. Fibrin structure and wound healing. J Thromb Haemost. 2006;4:932.
11. Hall CE, Slayter HS. The fibrinogenmolecule: its size, shape and mode of polymerization. J Biophy Biochem Cytol. 1958;5:11-16.
12. Mosesson MW, Siebenlist KR, Meh DA. The structure and biological features of fibrinogen and fibrin. Ann NY Acad Sci. 2001;936:11-30.
13. Ariens RA, Lai T-S, Weisel JW, et al. Role of Factor XIII in fibrin clot formation and effects of genetic polymorphisms. Blood. 2002;100:743-754.
14. Kannan R, Salacinski H, Sales K, et al. The roles of tissue engineering and vascularisation in the development of microvascular networks: a review. Biomaterials. 2005;26:1857-1875.
15. Geckil H, Xu F, Zhang X, et al. Engineering hydrogels as extracellular matrix mimics. Nanomedicine. 2010;5:469-484.
16. Blombfcck B, Carlsson K, Fatah K, et al. Fibrin in human plasma: gel architectures governed by rate and nature of fibrinogen activation. Thromb Res. 1994;75:521-538.
17. Soler-Illia GJ, de AA, Sanchez C, et al. Chemical strategies to design textured materials: from microporous and mesoporous oxides to nanonetworks and hierarchical structures. Chem Rev. 2002;102:4093-4138.
18. van Tienen T, Heijkants R, Buma P, et al. Tissue ingrowth and degradation of two biodegradable porous polymers with different porosities and pore sizes. Biomaterials. 2002; 23:1731-1738.
19. Wei J, Jia J, Wu F, et al. Hierarchically microporous/macroporous scaffold of magnesium-calcium phosphate for bone tissue regeneration. Biomaterials. 2010;31:1260-1269.
20. Otsuki B, Takemoto M, Fujibayashi S, et al. Pore throat size and connectivity determine bone and tissue ingrowth into porous implants: three-dimensional micro-CT based structural analyses of porous bioactive titanium implants. Biomaterials. 2006;27:5892-5900.
21. He S, Blombäck M, Ekman Jacobsson G, et al. The role of recombinant Factor VIIa (FVIIa) in fibrin structure in the absence of FVIII/FIX. J Thromb Haemost 2003;1:1215-1219.
22. Okada M, Blombäck B. Factors influencing fibrin gel structure studied by flow measurement. Ann NY Acad Sci. 2006; 408:233-253.
23. Standeven KF, Carter AM, Grant PJ, et al. Functional analysis of fibrin c-chain cross-linking by activated Factor XIII: determination of a cross-linking pattern that maximizes clot stiffness. Blood. 2007;110:902-907.
24. Antovic A, Perneby C, Ekman GJ, et al. Marked increase of fibrin gel permeability with very low dose ASA treatment. Thromb Res. 2005;116:509-517.
25. Hayen W, Goebeler M, Kumar S, et al. Hyaluronan stimulates tumor cell migration by modulating the fibrin fiber architecture. J Cell Sci. 1999;112:2241-2251.